临床试验/ISRCTN17833622

ISRCTN17833622已完成未知

AML 12 - Acute myeloid leukaemia Adults (modified)

Medical Research Council (MRC) (UK)0 个研究点目标入组 0 人开始时间: 2000年10月25日最近更新: 2019年8月26日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2001 results in http://www.ncbi.nlm.nih.gov/pubmed/11535508 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/16076872 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/19965647 2013 results in http://www.ncbi.nlm.nih.gov/pubmed/23439754 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24855211 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29025912 (added 25/07/2019)

研究设计

研究类型: Interventional

入排标准

性别: All

入选标准

•1. Acute myeloid leukaemia (AML) (any type of de novo or secondary AML, including acute promyelocytic leukemia [APL])
•2. Suitable for intensive therapy
•3. Normally under the age of 60 years (but older patients can be entered if considered suitable)
•4. Informed consent given

排除标准

•1. Previous cytotoxic therapy for leukaemia
•2. Concurrent active malignancy
•3. Blast transformation of CML
•4. Pregnant or lactating
•5. Intensive chemotherapy not considered to be an appropriate treatment option
•6. Patients with APL are not eligible for the ATRA randomisation

研究者

发起方

Medical Research Council (MRC) (UK)

相似试验

Acute Myeloid Leukaemia (AML) Trial 12 (modified) for patients aged under 60eukaemia (acute)LeukaemiaCancer

ISRCTN55678797Medical Research Council (MRC) (UK)500

Acute myeloid leukaemia (AML) trial 12 (protocol for children)eukaemiaLeukaemiaCancer

ISRCTN64649191Medical Research Council (MRC) (UK)2,000

Adults with Acute Myeloid Leukaemia or High-Risk Myelodysplastic Syndrome (AML19)Acute myeloid leukaemia and myelodysplastic syndromeCancer

ISRCTN78449203Cardiff University (UK)1,033

Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia

NCT06068868AbbVie36

Acute Myeloid Leukaemia - High Risk (AML-HR)LeukaemiaeukaemiaCancer

ISRCTN88373119Medical Research Council (MRC) (UK)600